Jupiter Asset Management’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-11,541
Closed -$392K 495
2022
Q4
$392K Hold
11,541
0.01% 417
2022
Q3
$351K Hold
11,541
0.01% 467
2022
Q2
$428K Sell
11,541
-2,560
-18% -$99.3K 0.01% 503
2022
Q1
$637K Sell
14,101
-1,520
-10% -$66.5K 0.01% 436
2021
Q4
$748K Hold
15,621
0.01% 435
2021
Q3
$868K Hold
15,621
0.01% 427
2021
Q2
$847K Sell
15,621
-5,693
-27% -$312K 0.01% 452
2021
Q1
$1.2M Sell
21,314
-4,654
-18% -$232K 0.01% 434
2020
Q4
$1.13M Buy
25,968
+5,966
+30% +$235K 0.01% 456
2020
Q3
$777K Buy
+20,002
New +$879K 0.01% 480

Other funds holding SRDX

Jupiter Asset Management's SRDX Position: Q1 2023 in Review

Jupiter Asset Management sold out of Surmodics (SRDX) in Q1 2023, closing a stake of 11,541 shares — an estimated $392K sold.

Jupiter Asset Management first reported a position in SRDX in Q3 2020 and held it in 10 quarters. The position peaked at $1.2M in Q1 2021. 119 funds tracked by Wall St. Rank hold SRDX as of Q1 2023.

  • Jupiter Asset Management reported no remaining Surmodics position as of Q1 2023 after selling out during the quarter.
  • Jupiter Asset Management sold 11,541 Surmodics shares in Q1 2023, an estimated $392K.
  • Jupiter Asset Management first reported a position in Surmodics in Q3 2020 and held it in 10 quarters.
  • Jupiter Asset Management's Surmodics position peaked at $1.2M in Q1 2021.
  • 119 funds tracked by Wall St. Rank held Surmodics as of Q1 2023.

Based on Jupiter Asset Management's 13F filing for Q1 2023, filed 10 May 2023.